Steffen E Meiler

Summary

Publications

  1. pmc Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
    Steffen E Meiler
    Department of Anesthesiology and Perioperative Medicine, Georgia Health Sciences University, Augusta, GA, USA
    Blood 118:1109-12. 2011

Detail Information

Publications1

  1. pmc Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
    Steffen E Meiler
    Department of Anesthesiology and Perioperative Medicine, Georgia Health Sciences University, Augusta, GA, USA
    Blood 118:1109-12. 2011
    ..Surprisingly, combinatory therapy with both drugs failed to mitigate hydroxyurea's myelotoxic effects and caused loss of HbF induction. These findings support further evaluation of pomalidomide as a novel therapy for SCD...